Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: AURO VACCINES LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-07-21 to 2026-12-31
Current total value of award: $10728082.6
Description: EO 14042 ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER